Literature DB >> 3040

[An improved trihydroxyindole method for the determination of urinary catecholamines].

U Werner.   

Abstract

Commercially available columns for ion exchange chromatography were used for the separation of catecholamines in urine. The estimation of catecholamines was performed fluorimetrically by a new trihydroxyindole method. The fluorescence of adrenaline or noradrenaline was enhanced, in comparison with other methods, by the combined application of boric acid, copper-ions, mercaptoethanol and final reacidification. The fluorophores are stable: The loss of fluorescence of adrenolutin amounted to 22% during 180 minutes, and there was no loss of noradrenolutin. For the differentiation of amines, adrenaline was oxidized at pH 2.85 and noradrenaline at pH 7. Precision, accuracy, sensitivity and specifity fulfilled the criteria of analysis. The normal values, determined in a collective of 17 healthy persons, were adrenaline (x +/- s) 44.8 +/- 16.9 nmol/24 h and noradrenaline (x +/- s) 224.0 +/- 68.0 nmol/24h. The simultaneous application of alpha-methyldopa (2 g/day) in 13 patients with primary hypertension did not disturb the fluorimetric estimation of catecholamines.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 3040

Source DB:  PubMed          Journal:  Z Klin Chem Klin Biochem        ISSN: 0044-2933


  3 in total

1.  Changes in platelet alpha 2-adrenoceptors in human phaeochromocytoma.

Authors:  O E Brodde; K D Bock
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

2.  Monoamine activity reflected in urine of young patients with obsessive compulsive disorder, psychosis with and without reality distortion and healthy subjects: an explorative analysis.

Authors:  R D Oades; B Röpcke; C Eggers
Journal:  J Neural Transm Gen Sect       Date:  1994

3.  Conservative and surgical management of incidentally discovered adrenal tumors (incidentalomas).

Authors:  F Jockenhövel; W Kuck; B Hauffa; W Reinhardt; G Benker; S Lederbogen; T Olbricht; D Reinwein
Journal:  J Endocrinol Invest       Date:  1992-05       Impact factor: 4.256

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.